MétaCan
Menu
Retour à la cohorte
Enregistrement W4375867176 · doi:10.22541/au.168352021.19204898/v1

Remission: Mission Possible in Chronic Rhinosinusitis with Nasal Polyposis?

2023· preprint· en· W4375867176 sur OpenAlexaffabout
Yvonne Chan, Andrew Thamboo, Jianlong Han, Martin Desrosiers

Notice bibliographique

Revuenon disponible
Typepreprint
Langueen
DomaineMedicine
ThématiqueSinusitis and nasal conditions
Établissements canadiensCentre Hospitalier de l’Université de MontréalUniversity of British ColumbiaUniversity of Toronto
Organismes subventionnairesnon disponible
Mots-clésMedicineOtorhinolaryngologyAsthmaNasal polypsChronic rhinosinusitisDiseaseInternal medicineSinusitisGastroenterologySurgery

Résumé

récupéré en direct d'OpenAlex

Remission: Mission Possible in Chronic Rhinosinusitis with Nasal Polyposis?To the Editor,Remission is emerging as the penultimate goal in the management of several chronic diseases. Recent application of these concepts to the management of inflammatory airway disease has promoted the concept of clinical remission, using a “Treat to Target” approach. The concept of remission, now well-established in Rheumatology as well as Gastroenterology (GI), is emerging in Respiratory Medicine with recent publication of definitions of clinical remission for asthma (1). It is interesting to consider whether the disease remission concept might successfully be applied to Otolaryngology-Head and Neck Surgery (OHNS) in the management of chronic rhinosinusitis with nasal polyposis (CRSwNP).In the treatment of asthma, ‘remission’ is defined as the elimination of exacerbations and stabilization of symptoms, with the possibility of normalizing inflammatory markers, which indirectly reflect lung function and inflammation. Guidelines for inflammatory digestive diseases are similar to those in asthma, in terms of their symptomatic endpoints and rigorous control of disease (2). However, for inflammatory bowel disorders unlike in asthma, an additional endoscopic criterion which documents epithelial and mucosal recovery from disease is also included. The nasal endoscope provides similar characterization for the control criteria in CRSwNP, incorporating symptom control signifying clinical remission with endoscopic remission demonstrating normal sinonasal mucosa, which can also incorporate inflammatory markers highlighting biochemical remission.A consensus statement from tertiary Canadian rhinologists has previously combined symptomatic and endoscopic assessments to define success after endoscopic sinus surgery (ESS), with ‘optimal’ results reported as absence of symptoms and normal appearance of the sinus mucosa on sinonasal endoscopy (3). However, it was unclear how frequently this ‘optimal’ outcome could be achieved. An estimate of remission rates in CRS care is now afforded by two recent studies in CRSwNP which employed a clinical endpoint very similar to the remission definition used in GI for inflammatory bowel diseases. The first study, a prospective trial which assessed outcomes after treatment of CRSwNP with endoscopic sinus surgery (4), and the second, a double-blinded, placebo-controlled prospective trial evaluating refractory CRSwNP managed with long-term, low dose azithromycin (5).After ESS, clinical endpoints resembling remission were attained in 50% of all subjects, but with different rates of remission for different populations distinguished by co-morbidities. At four months after surgery, 72% individuals undergoing primary ESS for CRSwNP attained remission, while those with a history of previous surgery showed lesser response, with a 42% remission rate. Asthmatic subjects did considerably worse than non-asthmatic subjects: non-asthmatics attained remission in 60%, while patients with asthma or with aspirin exacerbated respiratory disease (AERD) only showed remission in 23% and 23.5% of cases, respectively. For the azithromycin trial, there was a 54% remission rate overall. Again, asthma was associated with a worse outcome: non-asthmatics had a remission rate of 88%, while asthmatics achieved only 38% remission, and only in 14% of AERD patients. Individuals demonstrating remission were characterized by parameters of epithelial recovery and healing, approaching those of optimal control as suggested for inflammatory digestive diseases (6).Conclusion: Remission is indeed a concept that can be attained in CRSwNP, even in patients who failed previous surgery, as demonstrated by these findings. Some patient groups apparently have more difficult disease evolution, and asthma emerges as an important treatable trait in patients with CRSwNP. Better defining this outcome through consensus-based definitions will allow for the identification and stratification of clinical scenarios where patients have complete relief from their disease symptomatically in addition to biochemical and endoscopic normalization which penultimately achieving remission.Respectfully submitted,Yvonne Chan, Andrew Thamboo, Joseph Han, Martin Desrosiers

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,002
score de la tête « metaresearch » (Gemma)0,017
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,008
Score d'incertitude au seuil0,014

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0020,017
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0010,002
Communication savante0,0020,003
Science ouverte0,0020,001
Intégrité de la recherche0,0080,011
Charge utile insuffisante (le modèle a refusé de juger)0,0030,002

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,048
Tête enseignante GPT0,328
Écart entre enseignants0,280 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2023
Routes d'admission2
Résumé présentoui

Explorer davantage

Même sujetSinusitis and nasal conditionsTravaux en français237 207